Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Mulder

Showing results (201-210 of 369) with videos related to

Pageof 37
Sort By:
Cancer|November 1, 1986
Gastrointestinal toxicity of chemotherapy and the influence of hyperalimentationJ M Smit, N H Mulder, D T Sleijfer, et al.
Annals of Surgical Oncology|June 2, 1998
T-cell evaluation in patients with colon cancer: dinitrochlorobenzene skin testing versus plasma levels of sIL-2r and sCD8W A Bleeker, L de Ley, H B Oeseburg, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1984
Patient motivation and informed consent in a phase I study of an anticancer agentS Rodenhuis, W J van den Heuvel, A A Annyas, et al.
Cancer|March 1, 1986
Acute nonlymphocytic leukemia 5 years after treatment with cisplatin, vinblastine, and bleomycin for disseminated testicular cancerG W van Imhoff, D T Sleijfer, M H Breuning, et al.
International Journal of Cancer|December 15, 1987
Influence of docosahexaenoic acid in vitro on intracellular adriamycin concentration in lymphocytes and human adriamycin-sensitive and -resistant small-cell lung cancer cell lines, and on cytotoxicity in the tumor cell linesJ G Zijlstra, E G de Vries, F A Muskiet, et al.
Cancer Research|April 5, 2000
Monitoring of herpes simplex virus thymidine kinase enzyme activity using positron emission tomographyG A Hospers, A Calogero, A van Waarde, et al.
Blood|August 1, 1995
Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patientsJ Nieken, N H Mulder, J Buter, et al.
British Journal of Cancer|March 1, 1990
Pharmacokinetics of carboplatin at a dose of 750 mg m-2 divided over three consecutive daysP O Mulder, E G de Vries, D R Uges, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1986
Phase II study of bleomycin, actinomycin D, DTIC and vindesine in disseminated malignant melanomaN H Mulder, D T Sleijfer, J M Smit, et al.
British Journal of Cancer|December 1, 1995
Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell linesH J Groen, S Sleijfer, C Meijer, et al.
Pageof 37

Showing results (201-210 of 369) with videos related to

Sort By:
Pageof 37
Cancer|November 1, 1986
Gastrointestinal toxicity of chemotherapy and the influence of hyperalimentationJ M Smit, N H Mulder, D T Sleijfer, et al.
Annals of Surgical Oncology|June 2, 1998
T-cell evaluation in patients with colon cancer: dinitrochlorobenzene skin testing versus plasma levels of sIL-2r and sCD8W A Bleeker, L de Ley, H B Oeseburg, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1984
Patient motivation and informed consent in a phase I study of an anticancer agentS Rodenhuis, W J van den Heuvel, A A Annyas, et al.
Cancer|March 1, 1986
Acute nonlymphocytic leukemia 5 years after treatment with cisplatin, vinblastine, and bleomycin for disseminated testicular cancerG W van Imhoff, D T Sleijfer, M H Breuning, et al.
International Journal of Cancer|December 15, 1987
Influence of docosahexaenoic acid in vitro on intracellular adriamycin concentration in lymphocytes and human adriamycin-sensitive and -resistant small-cell lung cancer cell lines, and on cytotoxicity in the tumor cell linesJ G Zijlstra, E G de Vries, F A Muskiet, et al.
Cancer Research|April 5, 2000
Monitoring of herpes simplex virus thymidine kinase enzyme activity using positron emission tomographyG A Hospers, A Calogero, A van Waarde, et al.
Blood|August 1, 1995
Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patientsJ Nieken, N H Mulder, J Buter, et al.
British Journal of Cancer|March 1, 1990
Pharmacokinetics of carboplatin at a dose of 750 mg m-2 divided over three consecutive daysP O Mulder, E G de Vries, D R Uges, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1986
Phase II study of bleomycin, actinomycin D, DTIC and vindesine in disseminated malignant melanomaN H Mulder, D T Sleijfer, J M Smit, et al.
British Journal of Cancer|December 1, 1995
Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell linesH J Groen, S Sleijfer, C Meijer, et al.
Pageof 37